FDA supports standardized reporting and analysis on CGM devices

Diabetes Technology and Therapeutics

Volumn 15, Issue 4, 2013, Pages 348-

  Serrano, Katherine ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GLUCOSE MONITORING; CAREGIVER; COST; FOOD AND DRUG ADMINISTRATION; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HUMAN; LETTER; MEDICAL DEVICE; PRIORITY JOURNAL; STANDARDIZATION;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MONITORING, AMBULATORY;

EID: 84876114662     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.8313     Document Type: Letter

References (1)

1. Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM: Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: The Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 2013;15:198-211.